Editorial to Special Issue “Glioblastoma: Recapitulating the Key Breakthroughs and Future Perspective”-Reference-Cited by-同舟云学术

Editorial to Special Issue “Glioblastoma: Recapitulating the Key Breakthroughs and Future Perspective”

Published:2023-01-29 Issue:3 Volume:24 Page:2548
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Sharma Amit¹^ORCID,Guerrero-Cázares Hugo²^ORCID,Maciaczyk Jarek¹³^ORCID

Affiliation:

1. Department of Stereotactic and Functional Neurosurgery, University Hospital of Bonn, 53127 Bonn, Germany

2. Department of Neurological Surgery, Mayo Clinic, Jacksonville, FL 32224, USA

3. Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand

Abstract

Glioblastoma (GBM) remains the most common and aggressive malignant primary brain tumor [...]

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/24/3/2548/pdf

Reference31 articles.

1. Drongitis, D., Verrillo, L., De Marinis, P., Orabona, P., Caiola, A., Turitto, G., Alfieri, A., Bruscella, S., Gentile, M., and Moriello, V. (2022). The Chromatin-Oxygen Sensor Gene KDM5C Associates with Novel Hypoxia-Related Signatures in Glioblastoma Multiforme. Int. J. Mol. Sci., 23.

2. Carcelén, M., Velásquez, C., Vidal, V., Gutierrez, O., and Fernandez-Luna, J.L. (2022). HIF2α Upregulates the Migration Factor ODZ1 under Hypoxia in Glioblastoma Stem Cells. Int. J. Mol. Sci., 23.

3. Pinarbasi-Degirmenci, N., Sur-Erdem, I., Akcay, V., Bolukbasi, Y., Selek, U., Solaroglu, I., and Bagci-Onder, T. (2022). Chronically Radiation-Exposed Survivor Glioblastoma Cells Display Poor Response to Chk1 Inhibition under Hypoxia. Int. J. Mol. Sci., 23.

4. Zeneyedpour, L., Stingl, C., Kros, J.M., Sillevis Smitt, P.A.E., and Luider, T.M. (2022). Novel Antibody-Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma. Int. J. Mol. Sci., 23.

5. Choi, J., Bordeaux, Z.A., McKeel, J., Nanni, C., Sutaria, N., Braun, G., Davis, C., Miller, M.N., Alphonse, M.P., and Kwatra, S.G. (2022). GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma. Int. J. Mol. Sci., 23.